No black box warning on record for Sucraid

As of the latest FDA labeling reviewed, Sucraid (SACROSIDASE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Sucraid medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Severe Hypersensitivity Reactions Severe hypersensitivity reactions, including wheezing, rash, and pruritis, have been reported with administration of Sucraid. Sucraid contains papain, which is associated with hypersensitivity reactions (see DESCRIPTION). A pediatric patient in the clinical trials experienced a hypersensitivity reaction of severe wheezing that required hospitalization. Po

No black box warning on record for Sucraid

Other warnings & precautions

WARNINGS Severe Hypersensitivity Reactions Severe hypersensitivity reactions, including wheezing, rash, and pruritis, have been reported with administration of Sucraid. Sucraid contains papain, which is associated with hypersensitivity reactions (see DESCRIPTION). A pediatric patient in the clinical trials experienced a hypersensitivity reaction of severe wheezing that required hospitalization. Po

Sucraid Black Box Warning

No black box warning on record for Sucraid

Other warnings & precautions

Sucraid Black Box Warning

No black box warning on record for Sucraid

Other warnings & precautions